Opexa Pharmaceuticals, Inc. to Present at the Rodman & Renshaw 15th Annual Global Investment Conference

Opexa Therapeutics, Inc. (NASDAQ: OPXA), a biotechnology company developing Tcelna®, a patient-specific T-cell immunotherapy for the treatment of multiple sclerosis (MS), today announced that Neil K. Warma, Opexa’s President and Chief Executive Officer, will deliver a corporate presentation at the Rodman & Renshaw Annual Global Investment Conference. The conference will be held September 8-10th at The Millennium Broadway Hotel in New York City.

Help employers find you! Check out all the jobs and post your resume.